Tasuku Honjo

Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, Yoshida Sakyo-ku, Kyoto, Japan.

Publications of Tasuku Honjo

  • TRIM28 prevents autoinflammatory T cell development in vivo.

    Authors: Shunsuke Chikuma, Naomasa Suita, Il-Mi Okazaki, Shiro Shibayama, Tasuku Honjo

    Nature immunology. 04/2012;

    TRIM28 is a component of heterochromatin complexes whose function in the immune system is unknown. By studying mice with conditional T cell-specific deletion of TRIM28 (CKO mice), we found that
  • An evolutionary view of the mechanism for immune and genome diversity.

    Authors: Lucia Kato, Andre Stanlie, Nasim A Begum, Maki Kobayashi, Masatoshi Aida, Tasuku Honjo

    Journal of immunology (Baltimore, Md. : 1950). 04/2012; 188(8):3559-66.

    An ortholog of activation-induced cytidine deaminase (AID) was, evolutionarily, the first enzyme to generate acquired immune diversity by catalyzing gene conversion and probably somatic hypermutation
  • The DSIF Subunits Spt4 and Spt5 Have Distinct Roles at Various Phases of Immunoglobulin Class Switch Recombination.

    Authors: Andre Stanlie, Nasim A Begum, Hideo Akiyama, Tasuku Honjo

    PLoS genetics. 04/2012; 8(4):e1002675.

    Class-switch recombination (CSR), induced by activation-induced cytidine deaminase (AID), can be divided into two phases: DNA cleavage of the switch (S) regions and the joining of the cleaved ends of
  • Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes.

    Authors: Lucia Kato, Nasim A Begum, A Maxwell Burroughs, Tomomitsu Doi, Jun Kawai, Carsten O Daub, Takahisa Kawaguchi, Fumihiko Matsuda, Yoshihide Hayashizaki, Tasuku Honjo

    Proceedings of the National Academy of Sciences of the United States of America. 02/2012; 109(7):2479-84.

    Activation-induced cytidine deaminase (AID) is required for both somatic hypermutation and class-switch recombination in activated B cells. AID is also known to target nonimmunoglobulin genes and
  • The AID Dilemma: Infection, or Cancer?

    Authors: Tasuku Honjo, Maki Kobayashi, Nasim Begum, Ai Kotani, Somayeh Sabouri, Hitoshi Nagaoka

    Advances in cancer research. 01/2012; 113:1-44.

    Activation-induced cytidine deaminase (AID), which is both essential and sufficient for forming antibody memory, is also linked to tumorigenesis. AID is found in many B lymphomas, in myeloid
  • Decrease in topoisomerase I is responsible for activation-induced cytidine deaminase (AID)-dependent somatic hypermutation.

    Authors: Maki Kobayashi, Zahra Sabouri, Somayeh Sabouri, Yoko Kitawaki, Yves Pommier, Takaya Abe, Hiroshi Kiyonari, Tasuku Honjo

    Proceedings of the National Academy of Sciences of the United States of America. 11/2011; 108(48):19305-10.

    Somatic hypermutation (SHM) and class-switch recombination (CSR) of the Ig gene require both the transcription of the locus and the expression of activation-induced cytidine deaminase (AID). During
  • Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation.

    Authors: Il-mi Okazaki, Katsuya Okawa, Maki Kobayashi, Kiyotsugu Yoshikawa, Shimpei Kawamoto, Hitoshi Nagaoka, Reiko Shinkura, Yoko Kitawaki, Hisaaki Taniguchi, Tohru Natsume, Shun-Ichiro Iemura, Tasuku Honjo

    Proceedings of the National Academy of Sciences of the United States of America. 05/2011; 108(19):7920-5.

    Activation-induced cytidine deaminase (AID) is shown to be essential and sufficient to induce two genetic alterations in the Ig loci: class switch recombination (CSR) and somatic hypermutation (SHM).
  • Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense.

    Authors: Min Wei, Reiko Shinkura, Yasuko Doi, Mikako Maruya, Sidonia Fagarasan, Tasuku Honjo

    Nature immunology. 03/2011; 12(3):264-70.

    To elucidate the specific role of somatic hypermutation (SHM) in mucosal immunity, we generated mice carrying a knock-in point mutation in Aicda, which encodes activation-induced cytidine deaminase
  • IFN-α directly promotes programmed cell death-1 transcription and limits the duration of T cell-mediated immunity.

    Authors: Seigo Terawaki, Shunsuke Chikuma, Shiro Shibayama, Tamon Hayashi, Takao Yoshida, Taku Okazaki, Tasuku Honjo

    Journal of immunology (Baltimore, Md. : 1950). 03/2011; 186(5):2772-9.

    Programmed cell death-1 (PD-1) is an inhibitory coreceptor for T lymphocytes that provides feedback inhibition of T cell activation. Although PD-1's expression on T cells is known to be activation
  • PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice.

    Authors: Taku Okazaki, Il-mi Okazaki, Jian Wang, Daisuke Sugiura, Fumio Nakaki, Taku Yoshida, Yu Kato, Sidonia Fagarasan, Masamichi Muramatsu, Tomoo Eto, Kyoji Hioki, Tasuku Honjo

    The Journal of experimental medicine. 02/2011; 208(2):395-407.

    Stimulatory and inhibitory co-receptors play fundamental roles in the regulation of the immune system. We describe a new mouse model of spontaneous autoimmune disease. Activation-induced cytidine
  • Activation-induced cytidine deaminase expression in CD4+ T cells is associated with a unique IL-10-producing subset that increases with age.

    Authors: Hongyan Qin, Keiichiro Suzuki, Mikiyo Nakata, Shunsuke Chikuma, Nakako Izumi, Le Thi Huong, Mikako Maruya, Sidonia Fagarasan, Meinrad Busslinger, Tasuku Honjo, Hitoshi Nagaoka

    PloS one. 01/2011; 6(12):e29141.

    Activation-induced cytidine deaminase (AID), produced by the Aicda gene, is essential for the immunoglobulin gene (Ig) alterations that form immune memory. Using a Cre-mediated genetic system, we
  • Histone3 lysine4 trimethylation regulated by the facilitates chromatin transcription complex is critical for DNA cleavage in class switch recombination.

    Authors: Andre Stanlie, Masatoshi Aida, Masamichi Muramatsu, Tasuku Honjo, Nasim A Begum

    Proceedings of the National Academy of Sciences of the United States of America. 12/2010; 107(51):22190-5.

    Ig class switch recombination (CSR) requires expression of activation-induced cytidine deaminase (AID) and transcription through target switch (S) regions. Here we show that knockdown of the histone
  • PD-1 deficiency results in the development of fatal myocarditis in MRL mice.

    Authors: Jian Wang, Il-Mi Okazaki, Taku Yoshida, Shunsuke Chikuma, Yu Kato, Fumio Nakaki, Hiroshi Hiai, Tasuku Honjo, Taku Okazaki

    International immunology. 06/2010; 22(6):443-52.

    The deficiency of programmed cell death 1 (PD-1, Pdcd1), a negative immuno-receptor belonging to the CD28/cytotoxic T lymphocyte antigen 4 (CTLA-4) family, can support various tissue-specific
  • Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity.

    Authors: Hitoshi Nagaoka, Thinh Huy Tran, Maki Kobayashi, Masatoshi Aida, Tasuku Honjo

    International immunology. 03/2010; 22(4):227-35.

    Activation-induced cytidine deaminase (AID) is essential and sufficient to accomplish class-switch recombination and somatic hypermutation, which are two genetic events required for the generation of
  • Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice.

    Authors: Shimpei Kasagi, Seiji Kawano, Taku Okazaki, Tasuku Honjo, Akio Morinobu, Saori Hatachi, Kenichiro Shimatani, Yoshimasa Tanaka, Nagahiro Minato, Shunichi Kumagai

    Journal of immunology (Baltimore, Md. : 1950). 02/2010; 184(5):2337-47.

    Programmed cell death 1 (PD-1) is an immunosuppressive receptor that transduces an inhibitory signal into activated T cells. Although a single nucleotide polymorphism in the gene for PD-1 is
  • Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma.

    Authors: Ryosuke Hino, Kenji Kabashima, Yu Kato, Hiroaki Yagi, Motonobu Nakamura, Tasuku Honjo, Taku Okazaki, Yoshiki Tokura

    Cancer. 02/2010; 116(7):1757-66.

    : Melanoma tends to be refractory to various immunotherapies because of tumor-induced immunosuppression. To investigate the mechanism underlining the immunosuppression of melanoma patients, the
  • Two opposing roles of RBP-J in Notch signaling.

    Authors: Kenji Tanigaki, Tasuku Honjo

    Current topics in developmental biology. 01/2010; 92:231-52.

    RBP-J/Su(H)/Lag1, the main transcriptional mediator of Notch signaling, binds DNA with the consensus sequence YRTGDGAD. Notch target genes can be controlled by two opposing activities of RBP-J. The
  • B cell-specific and stimulation-responsive enhancers derepress Aicda by overcoming the effects of silencers.

    Authors: Thinh Huy Tran, Mikiyo Nakata, Keiichiro Suzuki, Nasim A Begum, Reiko Shinkura, Sidonia Fagarasan, Tasuku Honjo, Hitoshi Nagaoka

    Nature immunology. 12/2009;

    Activation-induced cytidine deaminase (AID) is essential for the generation of antibody memory but also targets oncogenes, among other genes. We investigated the transcriptional regulation of Aicda
  • AID-induced decrease in topoisomerase 1 induces DNA structural alteration and DNA cleavage for class switch recombination.

    Authors: Maki Kobayashi, Masatoshi Aida, Hitoshi Nagaoka, Nasim A Begum, Yoko Kitawaki, Mikiyo Nakata, Andre Stanlie, Tomomitsu Doi, Lucia Kato, Il-Mi Okazaki, Reiko Shinkura, Masamichi Muramatsu, Kazuo Kinoshita, Tasuku Honjo

    Proceedings of the National Academy of Sciences of the United States of America. 12/2009;

    To initiate class switch recombination (CSR) activation-induced cytidine deaminase (AID) induces staggered nick cleavage in the S region, which lies 5' to each Ig constant region gene and is rich in

Are you Tasuku Honjo?

Claim your profile

Keywords of Tasuku Honjo

Activation-induced cytidine deaminase
 
B cells
 
cell death 1
 
cytidine deaminase
 
DNA cleavage
 
Notch signaling
 
somatic hypermutation
 
T cell activation
 
T cells
 
transgenic mice
 
1544.74
Impact Points
143
Publications

Institutions

  • 2002–2012
    • Kyoto University
      • Graduate School of Medicine
      Kyoto, Kyoto-fu, Japan
  • 2011
    • The University of Tokushima
      Tokushima-shi, Tokushima-ken, Japan
  • 2010
    • Shiga Medical Center Research Institute
      Moriyama, Shiga-ken, Japan
  • 2003–2010
    • Osaka City University
      Kōbe-shi, Hyogo-ken, Japan
  • 2009
    • RIKEN Ltd.
      Saitama, Saitama-ken, Japan